Related Experiment Video
Updated: Jun 1, 2026
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial
Yuan Yuan Li1, Jian Guo Cui, Prerna Dua
1LSU Neuroscience Center, Department of Ophthalmology, Louisiana State University Health Science Center, New Orleans, LA 70112, USA.
Abstract:
MicroRNA-146a (miRNA-146a) is an inducible, 22 nucleotide, small RNA over-expressed in Alzheimer's disease (AD) brain. Up-regulated miRNA-146a targets several inflammation-related and membrane-associated messenger RNAs (mRNAs), including those encoding complement factor-H (CFH) and the interleukin-1 receptor associated kinase-1 (IRAK-1), resulting in significant decreases in their expression (p<0.05, ANOVA). In this study we assayed miRNA-146a, CFH, IRAK-1 and tetraspanin-12 (TSPAN12), abundances in primary human neuronal-glial (HNG) co-cultures, in human astroglial (HAG) and microglial (HMG) cells stressed with Aβ42 peptide and tumor necrosis factor alpha (TNFα). The results indicate a consistent inverse relationship between miRNA-146a and CFH, IRAK-1 and TSPAN12 expression levels, and indicate that HNG, HAG and HMG cell types each respond differently to Aβ42-peptide+TNFα-triggered stress. While the strongest miRNA-146a-IRAK-1 response was found in HAG cells, the largest miRNA-146a-TSPAN12 response was found in HNG cells, and the most significant miRNA-146a-CFH changes were found in HMG cells, the 'resident scavenging macrophages' of the brain.
Insights
Alzheimer's disease (AD) involves increased microRNA-146a (miRNA-146a), which inversely affects inflammation-related genes like CFH and IRAK-1 in brain cells. Different cell types show unique responses to stress, impacting gene expression.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- MicroRNA-146a (miRNA-146a) is upregulated in Alzheimer's disease (AD) brains.
- miRNA-146a targets inflammation-related mRNAs, including complement factor-H (CFH) and interleukin-1 receptor associated kinase-1 (IRAK-1), reducing their expression.
Purpose of the Study:
- To investigate the expression of miRNA-146a, CFH, IRAK-1, and tetraspanin-12 (TSPAN12) in different human brain cell types under stress.
- To determine the relationship between miRNA-146a and these target genes in response to Alzheimer's-associated stressors.
Main Methods:
- Assayed miRNA-146a, CFH, IRAK-1, and TSPAN12 levels in primary human neuronal-glial (HNG), human astroglial (HAG), and human microglial (HMG) cells.
- Exposed cells to amyloid-beta 42 peptide (Aβ42) and tumor necrosis factor alpha (TNFα) to simulate stress.
Main Results:
- A consistent inverse relationship was observed between miRNA-146a and the expression of CFH, IRAK-1, and TSPAN12.
- HNG, HAG, and HMG cells exhibited distinct responses to Aβ42 + TNFα stress.
- The most significant changes in miRNA-146a-CFH, miRNA-146a-IRAK-1, and miRNA-146a-TSPAN12 were observed in HMG, HAG, and HNG cells, respectively.
Conclusions:
- miRNA-146a plays a role in regulating key genes involved in inflammation and cellular stress response in the brain.
- Differential cellular responses highlight the complex interplay of miRNA-146a in various glial and neuronal cell types during neuroinflammation.
- Findings suggest miRNA-146a as a potential therapeutic target for Alzheimer's disease by modulating specific gene expressions in distinct brain cell populations.
